Loading chat...
GA SR783
Resolution
Status
Introduced
2/14/2018
Primary Sponsor
Jeff Mullis
Click for details
AI Summary
- Creates the Joint Study Committee on Risks Associated with Kratom, composed of 6 members — 3 Senate members appointed by the President of the Senate and 3 House members appointed by the Speaker, with one cochairperson designated from each chamber
- Directs the committee to study the use, risks, and public health concerns associated with kratom, including its marketing as an opioid painkiller replacement and addiction treatment, and to recommend any necessary action or legislation
- Notes that FDA Commissioner Scott Gottlieb declared kratom an opioid on February 6, 2018, and that U.S. poison control center calls regarding kratom increased ten-fold from 2010 to 2015
- Provides committee members with allowances under O.C.G.A. § 28-1-8 for up to 5 days, funded from existing Senate and House appropriations
- Requires any findings or proposed legislation to be filed with the Secretary of the Senate and Clerk of the House by majority quorum vote, and sets the committee's abolishment date as December 1, 2018
Legislative Description
Joint Study Committee on Risks Associated with Kratom; create
Last Action
Senate Read and Referred
2/15/2018
Full Bill Text
No bill text available